Pharma
HIMSS25
Genetic therapy is effective but can cost millions of dollars. Boro Dropulić, executive director of Caring Cross, says technology innovations and partnerships with hospitals and governments can help lower costs and increase accessibility.
It joins Lunit and Us2.ai in the vendor-neutral, cloud-based marketplace of medical AI solutions.
HIMSS25
Michele Krajewski, HIMSS' Global Health Conference Education Committee chair, explains how the committee ensures each year's conference curriculum reflects the interests and needs of HIMSS' diverse membership.
Americans with a prescription will have access to Novo Nordisk's obesity drug Wegovy through the Hims & Hers platform for $599 monthly.
Juan Lavista Ferres, CVP and chief data scientist at Microsoft's AI for Good Lab, and Meghana Kshirsagar, senior research scientist, discuss their research on protein symmetry.
Lilly accuses four compounders of selling unauthorized versions of the pharma giant's diabetes and weight-loss drugs.
Michael Ramey, managing principal of Strategic & Transaction Solutions at PYA says due to changes in the FTC's new premerger notification rules, he's advising clients to be prepared to disclose more information and undergo greater scrutiny.
The projects will make use of genome sequencing data for more personalized, preventative and cost-effective healthcare.
Trace will use Unlearn's digital twin generator for ALS to create digital twins of clinical trial participants to advance ALS research.
The judge ruled that the FDA overstepped its authority by regulating LDTs as medical devices, overturning the rule and remanding it to the HHS Secretary for review.